InSilicoTrials Profile Banner
InSilicoTrials Profile
InSilicoTrials

@InSilicoTrials

Followers
1K
Following
2K
Media
712
Statuses
2K

Accelerate innovation in #healthcare! Leverage cutting-edge #technology to digitalize R&D, improve safety of #drugs & reduce in vivo testing.

Joined March 2020
Don't wanna be here? Send us removal request.
@InSilicoTrials
InSilicoTrials
1 year
๐ŸŽ‰ InSilicoTrials wins AI Startup of the Year at @StartupGrind Global 2024! Out of 650 startups, our innovative AI-driven platform stood out. Kudos to our CEO Emili & COO @TorchiaMario for showcasing our mission to revolutionize #healthcare with #insilico tech #AI #simulation
2
2
9
@InSilicoTrials
InSilicoTrials
6 days
Today marks the last day of ๐—•๐—œ๐—ข ๐—˜๐˜‚๐—ฟ๐—ผ๐—ฝ๐—ฒ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฑ, and this yearโ€™s edition in Vienna, Austria, has once again been a great success at the worldโ€™s leading expo in biotechnology and life sciences. Our VP of Business Development, Sofia Stathopoulos, and COO, Mario Torchia,
0
0
0
@InSilicoTrials
InSilicoTrials
2 months
๐—›๐—ฎ๐—ป๐—ฑ๐˜€-๐—ข๐—ป ๐—ช๐—ผ๐—ฟ๐—ธ๐˜€๐—ต๐—ผ๐—ฝ ๐—ผ๐—ป ๐—–๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐—ง๐—ฟ๐—ถ๐—ฎ๐—น ๐—ฆ๐—ถ๐—บ๐˜‚๐—น๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ฎ๐˜ ๐—”๐—–๐—ผ๐—ฃ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฑ! ๐—ง๐—ต๐˜‚๐—ฟ๐˜€๐—ฑ๐—ฎ๐˜†, ๐—ข๐—ฐ๐˜๐—ผ๐—ฏ๐—ฒ๐—ฟ ๐Ÿฎ๐Ÿฏ, ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฑ ๐—ฅ๐—ฒ๐—ฑ ๐—ฅ๐—ผ๐—ฐ๐—ธ ๐Ÿฏ, ๐—š๐—ฎ๐˜†๐—น๐—ผ๐—ฟ๐—ฑ ๐—ฅ๐—ผ๐—ฐ๐—ธ๐—ถ๐—ฒ๐˜€, ๐—”๐˜‚๐—ฟ๐—ผ๐—ฟ๐—ฎ, ๐—–๐—ผ๐—น๐—ผ๐—ฟ๐—ฎ๐—ฑ๐—ผ ๐Ÿด:๐Ÿฌ๐Ÿฌ ๐—”๐—  โ€“ ๐Ÿฑ:๐Ÿฌ๐Ÿฌ ๐—ฃ๐—  Join
0
0
1
@InSilicoTrials
InSilicoTrials
3 months
๐—›๐—ฒ๐—ฎ๐—ฑ๐—ถ๐—ป๐—ด ๐˜๐—ผ ๐—”๐—–๐—ผ๐—ฃ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฑ? Hereโ€™s where to find us, and get hands-on with clinical trial simulation. ๐—ข๐˜‚๐—ฟ ๐—ช๐—ผ๐—ฟ๐—ธ๐˜€๐—ต๐—ผ๐—ฝ ๐—›๐—ฎ๐—ป๐—ฑ๐˜€-๐—ข๐—ป ๐—œ๐—ป๐˜๐—ฟ๐—ผ๐—ฑ๐˜‚๐—ฐ๐˜๐—ถ๐—ผ๐—ป ๐˜๐—ผ ๐—–๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐—ง๐—ฟ๐—ถ๐—ฎ๐—น ๐—ฆ๐—ถ๐—บ๐˜‚๐—น๐—ฎ๐˜๐—ถ๐—ผ๐—ป Thursday, October 23 | 8:00 AM โ€“ 5:00 PM
0
0
0
@InSilicoTrials
InSilicoTrials
4 months
Join us at ๐—”๐—–๐—ผ๐—ฃ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฑ for a full-day, hands-on workshop on clinical trial simulation! โ€œ๐—›๐—ฎ๐—ป๐—ฑ๐˜€-๐—ข๐—ป ๐—œ๐—ป๐˜๐—ฟ๐—ผ๐—ฑ๐˜‚๐—ฐ๐˜๐—ถ๐—ผ๐—ป ๐˜๐—ผ ๐—–๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐—ง๐—ฟ๐—ถ๐—ฎ๐—น ๐—ฆ๐—ถ๐—บ๐˜‚๐—น๐—ฎ๐˜๐—ถ๐—ผ๐—ปโ€ ๐—ง๐—ต๐˜‚๐—ฟ๐˜€๐—ฑ๐—ฎ๐˜†, ๐—ข๐—ฐ๐˜๐—ผ๐—ฏ๐—ฒ๐—ฟ ๐Ÿฎ๐Ÿฏ | ๐Ÿด:๐Ÿฌ๐Ÿฌ ๐—”๐—  โ€“ ๐Ÿฑ:๐Ÿฌ๐Ÿฌ ๐—ฃ๐—  ๐—ฅ๐—ฒ๐—ฑ ๐—ฅ๐—ผ๐—ฐ๐—ธ ๐Ÿฏ |
lnkd.in
This link will take you to a page thatโ€™s not on LinkedIn
0
0
0
@InSilicoTrials
InSilicoTrials
4 months
๐—ช๐—ผ๐—ฟ๐—น๐—ฑ ๐—•๐—ฟ๐—ฎ๐—ถ๐—ป ๐——๐—ฎ๐˜† ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฑ ๐˜„๐—ถ๐˜๐—ต ๐—œ๐—ป๐—ฆ๐—ถ๐—น๐—ถ๐—ฐ๐—ผ๐—ง๐—ฟ๐—ถ๐—ฎ๐—น๐˜€ Today marks ๐—ช๐—ผ๐—ฟ๐—น๐—ฑ ๐—•๐—ฟ๐—ฎ๐—ถ๐—ป ๐——๐—ฎ๐˜†, a reminder that neurological diseases like ๐—”๐—Ÿ๐—ฆ and ๐— ๐—ฆ are among the most complex and devastating, but with the right tools, we can turn data into insight,
0
0
0
@InSilicoTrials
InSilicoTrials
4 months
๐—ช๐—ผ๐—ฟ๐—น๐—ฑ ๐—”๐—œ ๐——๐—ฎ๐˜†, ๐—–๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐—ง๐—ฟ๐—ถ๐—ฎ๐—น๐˜€, ๐—ฎ๐—ป๐—ฑ ๐˜๐—ต๐—ฒ ๐—ฅ๐—ถ๐˜€๐—ฒ ๐—ผ๐—ณ ๐—ฆ๐˜†๐—ป๐˜๐—ต๐—ฒ๐˜๐—ถ๐—ฐ ๐——๐—ฎ๐˜๐—ฎ Innovating with AI in healthcare and drug development comes with responsibility. At @InSilicoTrials, we prioritize responsible AI practices to ensure our models are
0
0
1
@InSilicoTrials
InSilicoTrials
4 months
In healthcare and drug development, synthetic data is gaining traction, but the term is being used in vastly different ways. We just published a new blog post exploring this very question, alongside our supporting paper: "๐—ฆ๐˜†๐—ป๐˜๐—ต๐—ฒ๐˜๐—ถ๐—ฐ ๐——๐—ฎ๐˜๐—ฎ ๐—ถ๐—ป ๐—›๐—ฒ๐—ฎ๐—น๐˜๐—ต๐—ฐ๐—ฎ๐—ฟ๐—ฒ
insilicotrials.com
Explore how synthetic data is transforming healthcare and drug development while addressing privacy, regulatory, and transparency challenges.
0
0
1
@InSilicoTrials
InSilicoTrials
4 months
Montrealโ€™s @AACR ๐—ฆ๐—ฝ๐—ฒ๐—ฐ๐—ถ๐—ฎ๐—น ๐—–๐—ผ๐—ป๐—ณ๐—ฒ๐—ฟ๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ถ๐—ป ๐—–๐—ฎ๐—ป๐—ฐ๐—ฒ๐—ฟ ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต: ๐—”๐—œ ๐—ฎ๐—ป๐—ฑ ๐— ๐—ฎ๐—ฐ๐—ต๐—ถ๐—ป๐—ฒ ๐—Ÿ๐—ฒ๐—ฎ๐—ฟ๐—ป๐—ถ๐—ป๐—ด has kicked off, with our VP of Business Development, Sofia Stathopoulos, taking part. From advanced simulations to innovative AI applications,
0
0
0
@InSilicoTrials
InSilicoTrials
4 months
๐—ข๐˜‚๐—ฟ ๐—ช๐—ถ๐—ป ๐—ฎ๐˜ ๐˜๐—ต๐—ฒ ๐—”๐—œ ๐—ฆ๐˜‚๐—บ๐—บ๐—ถ๐˜ ๐—Ÿ๐—ผ๐—ป๐—ฑ๐—ผ๐—ป ๐—™๐—ฒ๐—ฎ๐˜๐˜‚๐—ฟ๐—ฒ๐—ฑ ๐—ถ๐—ป ๐—˜๐—ป๐˜๐—ฟ๐—ฒ๐—ฝ๐—ฟ๐—ฒ๐—ป๐—ฒ๐˜‚๐—ฟ ๐—จ๐—ž! @EntrepreneurUK covered our win in the pitching competition at ๐—ง๐—ต๐—ฒ ๐—”๐—œ ๐—ฆ๐˜‚๐—บ๐—บ๐—ถ๐˜ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฑ, spotlighting why @InSilicoTrials stood out in one of Europeโ€™s most
Tweet card summary image
entrepreneur.com
Fresh off their The AI Summit London win, InSilicoTrials is turning regulatory-grade AI into the backbone of next-gen drug development.
0
0
0
@InSilicoTrials
InSilicoTrials
4 months
๐——๐—˜๐— ๐Ÿญ๐Ÿฌ ๐—ฅ๐—ฒ๐—ฐ๐—ฎ๐—ฝ ๐—ณ๐—ฟ๐—ผ๐—บ ๐—›๐—ถ๐—บ๐—ฒ๐—ท๐—ถ From particle modeling to AI-driven simulation, ๐——๐—˜๐— ๐Ÿญ๐Ÿฌ in Himeji, Japan brought together the brightest minds in particulate systems. Alongside our partner @RCPE, @InSilicoTrials was proud to support this important event and help
0
0
0
@InSilicoTrials
InSilicoTrials
4 months
Join our CEO Luca Emili on ๐—๐˜‚๐—น๐˜† ๐Ÿญ๐Ÿฌ ๐Ÿญ๐Ÿฑ:๐Ÿฐ๐Ÿฌ-๐Ÿญ๐Ÿฒ:๐Ÿฎ๐Ÿฌ ๐—–๐—˜๐—ฆ๐—ง as he takes the virtual stage at a webinar hosted by AICRO, the Italian Association of Contract Research Organizations. His session, โ€œ๐—œ๐—ป๐—ฐ๐—ฟ๐—ฒ๐—ฎ๐˜€๐—ถ๐—ป๐—ด ๐˜๐—ต๐—ฒ ๐—–๐—ผ๐—บ๐—บ๐—ฒ๐—ฟ๐—ฐ๐—ถ๐—ฎ๐—น ๐—ฉ๐—ฎ๐—น๐˜‚๐—ฒ ๐—ผ๐—ณ
Tweet card summary image
aicro.it
Lโ€™intelligenza artificiale non รจ piรน fantascienza: รจ una rivoluzione in atto. Il webinar si propone di fare chiarezza sui concetti base (machine learning, reti neurali e deep learning, LLM) fino ad...
0
0
0
@InSilicoTrials
InSilicoTrials
4 months
๐—–๐—ฎ๐—ป ๐—”๐—ฟ๐˜๐—ถ๐—ณ๐—ถ๐—ฐ๐—ถ๐—ฎ๐—น ๐—œ๐—ป๐˜๐—ฒ๐—น๐—น๐—ถ๐—ด๐—ฒ๐—ป๐—ฐ๐—ฒ ๐˜๐—ฟ๐˜‚๐—น๐˜† ๐˜๐—ฟ๐—ฎ๐—ป๐˜€๐—ณ๐—ผ๐—ฟ๐—บ ๐—ต๐—ผ๐˜„ ๐˜„๐—ฒ ๐—ณ๐—ถ๐—ด๐—ต๐˜ ๐—ฐ๐—ฎ๐—ป๐—ฐ๐—ฒ๐—ฟ? Next week, our VP of Business Development, Sofia Stathopoulos, will be inย Montreal for theย @AACR ๐—ฆ๐—ฝ๐—ฒ๐—ฐ๐—ถ๐—ฎ๐—น ๐—–๐—ผ๐—ป๐—ณ๐—ฒ๐—ฟ๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ถ๐—ป ๐—–๐—ฎ๐—ป๐—ฐ๐—ฒ๐—ฟ
0
1
2
@InSilicoTrials
InSilicoTrials
4 months
๐—ช๐—ฒโ€™๐—ฟ๐—ฒ ๐—ฝ๐—ฟ๐—ผ๐˜‚๐—ฑ ๐˜๐—ผ ๐˜€๐—ต๐—ฎ๐—ฟ๐—ฒ ๐˜๐—ต๐—ฎ๐˜ ๐—ผ๐˜‚๐—ฟ ๐—ฐ๐—ผ๐—น๐—น๐—ฎ๐—ฏ๐—ผ๐—ฟ๐—ฎ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—ฟ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต ๐˜„๐—ถ๐˜๐—ต Luigi Rovito, ๐—ฃ๐—ผ๐˜€๐˜-๐——๐—ผ๐—ฐ ๐—ฟ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต๐—ฒ๐—ฟ ๐—ฎ๐˜ ๐˜๐—ต๐—ฒ Universitร  degli Studi di Trieste (@UniTrieste), ๐—ต๐—ฎ๐˜€ ๐—ฏ๐—ฒ๐—ฒ๐—ป ๐—ฎ๐—ฐ๐—ฐ๐—ฒ๐—ฝ๐˜๐—ฒ๐—ฑ ๐—ฎ๐˜ @GeccoConf ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฑ.
0
0
0
@InSilicoTrials
InSilicoTrials
5 months
๐— ๐—ฒ๐—ฒ๐˜ InSilicoTrials ๐—ฎ๐˜ ๐—˜๐—”๐—–๐—ฃ๐—ง ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฑ! From June 28 to July 1,ย Maud Beneton, our Director of Clinical Pharmacology, will be on the ground inย Helsinki forย @EACPT ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฑ, a key meeting where Europe's pharmacology community comes together. She'll be presenting a
0
0
0
@InSilicoTrials
InSilicoTrials
5 months
@InSilicoTrials ๐—ป๐—ฎ๐—บ๐—ฒ๐—ฑ ๐—ผ๐—ป๐—ฒ ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐—ณ๐—ฎ๐˜€๐˜๐—ฒ๐˜€๐˜-๐—ด๐—ฟ๐—ผ๐˜„๐—ถ๐—ป๐—ด ๐˜€๐˜๐—ฎ๐—ฟ๐˜๐˜‚๐—ฝ๐˜€ ๐—ฏ๐˜† ๐—ฆ๐—ถ๐—ณ๐˜๐—ฒ๐—ฑ Weโ€™re proud to be featured in the ๐—ฆ๐—ถ๐—ณ๐˜๐—ฒ๐—ฑ ๐Ÿญ๐Ÿฌ๐Ÿฌ โ€“ France & Southern Europe 2025, a list that highlights the most promising and fastest-growing startups, based on
Tweet card summary image
sifted.eu
The Sifted 100: France & Southern Europe ranks the fastest-growing startups in France and Southern Europe by revenue growth on an annual basis. The deadline for applications is May 9, 2025.
0
0
0
@InSilicoTrials
InSilicoTrials
5 months
๐—™๐—ผ๐˜‚๐—ฟ ๐—ฑ๐—ฎ๐˜†๐˜€ ๐—ฎ๐˜ ๐—•๐—œ๐—ข ๐—œ๐—ป๐˜๐—ฒ๐—ฟ๐—ป๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—–๐—ผ๐—ป๐˜ƒ๐—ฒ๐—ป๐˜๐—ถ๐—ผ๐—ป ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฑ! BIO International Convention 2025 in Boston is ending today, and what a remarkable gathering of innovation, vision, and opportunity it has been. @InSilicoTrials was proud to be part of this
0
0
0
@InSilicoTrials
InSilicoTrials
5 months
๐—˜๐—”๐—–๐—ฃ๐—ง ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฑ, ๐—›๐—ฒ๐—น๐˜€๐—ถ๐—ป๐—ธ๐—ถ, ๐—™๐—ถ๐—ป๐—น๐—ฎ๐—ป๐—ฑ | ๐Ÿฎ๐Ÿด ๐—๐˜‚๐—ป๐—ฒ - ๐Ÿญ ๐—๐˜‚๐—น๐˜† The ๐—˜๐—”๐—–๐—ฃ๐—ง ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฑ ๐—–๐—ผ๐—ป๐—ด๐—ฟ๐—ฒ๐˜€๐˜€ is just around the corner, bringing together global leaders in clinical pharmacology to exchange insights that shape the future of patient care. Maud
0
0
0
@InSilicoTrials
InSilicoTrials
5 months
Next week,ย June 16-19, our team CEOย Luca Emili, COOย @TorchiaMario, and VP of Business Developmentย Sofia Stathopoulos will be at theย BIO International Convention 2025. It promises to be aย week full of networking, meetings, and meaningful conversations at one of the most
0
0
0
@InSilicoTrials
InSilicoTrials
5 months
@InSilicoTrials ๐—ท๐—ผ๐—ถ๐—ป๐˜€ ๐˜๐—ต๐—ฒ Microsoft for Startups ๐—ฃ๐—ฒ๐—ด๐—ฎ๐˜€๐˜‚๐˜€ ๐—ฃ๐—ฟ๐—ผ๐—ด๐—ฟ๐—ฎ๐—บ, ๐—ฎ๐—ป๐—ฑ ๐—ณ๐—ผ๐—ฟ ๐˜‚๐˜€, ๐˜๐—ต๐—ถ๐˜€ ๐—ถ๐˜€ ๐—ฎ ๐—ฝ๐—ผ๐˜„๐—ฒ๐—ฟ๐—ณ๐˜‚๐—น ๐—ฟ๐—ฒ๐—ฐ๐—ผ๐—ด๐—ป๐—ถ๐˜๐—ถ๐—ผ๐—ป. When we started, our goal was clear:ย ๐—ฏ๐—ฟ๐—ถ๐—ป๐—ด ๐—ฐ๐˜‚๐˜๐˜๐—ถ๐—ป๐—ด-๐—ฒ๐—ฑ๐—ด๐—ฒ ๐˜€๐—ถ๐—บ๐˜‚๐—น๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ฎ๐—ป๐—ฑ ๐—”๐—œ ๐˜๐—ผ
0
0
0
@InSilicoTrials
InSilicoTrials
5 months
๐—–๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐˜๐—ฟ๐—ถ๐—ฎ๐—น๐˜€ ๐—ฎ๐—ฟ๐—ฒ ๐—ฒ๐˜ƒ๐—ผ๐—น๐˜ƒ๐—ถ๐—ป๐—ด, ๐—ฎ๐—ป๐—ฑ ๐—”๐—œ ๐—ถ๐˜€ ๐—ฎ๐˜ ๐˜๐—ต๐—ฒ ๐—ฐ๐—ฒ๐—ป๐˜๐—ฒ๐—ฟ ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐˜๐—ฟ๐—ฎ๐—ป๐˜€๐—ณ๐—ผ๐—ฟ๐—บ๐—ฎ๐˜๐—ถ๐—ผ๐—ป. Meet us June 18-19 at @HITHealthIMPACT, hosted at @Microsoft's NYC offices in Times Square, and discover how we're helping shape the future
0
2
3